EMA/PE/0000239193
EMA/PE/0000239193
EMA/PE/0000239193
EMA/PE/0000228269
Opinion/decision on a Paediatric investigation plan (PIP): Exparel liposomal, bupivacaine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: P/0021/2024
Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 72, Status: Authorised
EMA/PE/0000237870
EMA/PE/0000229480
Human medicines European public assessment report (EPAR): Mulpleo (previously Lusutrombopag Shionogi), lusutrombopag, Date of authorisation: 18/02/2019, Revision: 9, Status: Withdrawn
Human medicines European public assessment report (EPAR): Erelzi, etanercept, Date of authorisation: 23/06/2017, Revision: 19, Status: Authorised
Plasma master file certificates
Human medicines European public assessment report (EPAR): Stocrin, efavirenz, Date of authorisation: 28/05/1999, Revision: 49, Status: Withdrawn